A Note Before You Begin Weight loss injections have become one of the most searched health topics of the past three years, and for good reason. GLP-1 receptor agonists such as semaglutide and tirzepatide have delivered clinical results that were once considered impossible without surgery: 15 to 22 percent total body weight loss in randomised controlled trials, with meaningful improvements in blood sugar, blood pressure, and cardiovascular risk markers. The surge in demand has

Two medications now dominate the conversation around medical weight management in the Philippines: Mounjaro and Wegovy. Both are weekly injectable medications. Both produce clinically meaningful weight loss. Both have generated enormous interest among Filipino patients, and both have generated an equal amount of confusion about which is the better choice. The question of Mounjaro vs Wegovy Philippines is genuinely important because the two medications, while related, are not